Physician profile
Nishant Reddy
NPI 1780974899
$132,722.11
in general payments reported to CMS, 2019-2025
17 companies · $53K in 2025
The $53K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $172 · 2021: $3,146 · 2022: $33K · 2023: $31K · 2024: $12K · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $82K · Travel and Lodging: $8,715 · Food and Beverage: $5,302 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $81,900.00 |
| Travel and Lodging | $8,715.24 |
| Food and Beverage | $5,301.55 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $127,118.80 | 2021-2025 | Nucala |
| Stryker Corporation | $1,855.59 | 2022-2025 | Scopis Ent, Xpress Ent Dilation System, Audion Et Dilation System |
| Aerin Medical INC. | $1,674.55 | 2022-2025 | |
| Optinose US, INC. | $672.20 | 2020-2025 | |
| Genzyme Corporation | $441.11 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $370.56 | 2021-2024 | Dupixent, Libtayo |
| Astrazeneca Pharmaceuticals Lp | $285.53 | 2022-2025 | Tezspire |
| Sanofi-Aventis U.S. LLC | $89.99 | 2024 | |
| Medtronic, INC. | $64.96 | 2023-2025 | Propel |
| Merck Sharp & Dohme LLC | $30.26 | 2022-2023 | |
| Cochlear Americas | $23.07 | 2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Alk-Abello, INC | $17.74 | 2020 | |
| Revance Therapeutics, INC. | $16.20 | 2025 | Daxxify |
| Paratek Pharmaceuticals, INC. | $15.81 | 2025 | Xhance |
| Hologic Sales and Service, LLC | $15.68 | 2025 | Coolseal Generator |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $15.51 | 2020 | |
| Hikma Pharmaceuticals USA | $14.55 | 2024 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nishant Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.